<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hawkins KE</submitter><funding>NINDS NIH HHS</funding><pagination>14</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3620676</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Matrix metalloproteinases are important factors in the molecular mechanisms leading to neuronal injury in many neurological disorders. Matrix metalloproteinase (MMP)-9 is up-regulated after cerebral ischemia and neuroinflammation and is actively involved in blood-brain barrier disruption. Current methods of measuring MMP-9 activity, such as gelatin-substrate zymography, are unspecific and arduous. Here we developed an immunocapture assay with high efficiency, specificity, and sensitivity for quantifying endogenously active as well as total MMP-9 activity.&lt;h4>Results&lt;/h4>A fluorescence resonance energy transfer (FRET) peptide-based immunocapture assay was developed that enables the accurate assessment of total and active forms of MMP-9 in complex biological samples. The F</pubmed_abstract><journal>Molecular brain</journal><pubmed_title>Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke.</pubmed_title><pmcid>PMC3620676</pmcid><funding_grant_id>R01 NS065849</funding_grant_id><pubmed_authors>Candelario-Jalil E</pubmed_authors><pubmed_authors>Rosenberg GA</pubmed_authors><pubmed_authors>Hawkins KE</pubmed_authors><pubmed_authors>DeMars KM</pubmed_authors><pubmed_authors>Yang C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke.</name><description>&lt;h4>Background&lt;/h4>Matrix metalloproteinases are important factors in the molecular mechanisms leading to neuronal injury in many neurological disorders. Matrix metalloproteinase (MMP)-9 is up-regulated after cerebral ischemia and neuroinflammation and is actively involved in blood-brain barrier disruption. Current methods of measuring MMP-9 activity, such as gelatin-substrate zymography, are unspecific and arduous. Here we developed an immunocapture assay with high efficiency, specificity, and sensitivity for quantifying endogenously active as well as total MMP-9 activity.&lt;h4>Results&lt;/h4>A fluorescence resonance energy transfer (FRET) peptide-based immunocapture assay was developed that enables the accurate assessment of total and active forms of MMP-9 in complex biological samples. The F</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Mar</publication><modification>2025-04-26T10:32:24.794Z</modification><creation>2019-03-27T01:07:10Z</creation></dates><accession>S-EPMC3620676</accession><cross_references><pubmed>23522154</pubmed><doi>10.1186/1756-6606-6-14</doi></cross_references></HashMap>